Ketamind Clinic Israel - depression statistics israel - depression therapy - ketamine therapy

Depression Statistics in Israel: Understanding the Magnitude and Impact

Depression, an insidious mental health disorder, has worldwide implications, adversely impacting millions’ quality of life and work productivity. Affecting individuals across the globe, its ramifications are not uniform, varying greatly based on cultural, socioeconomic, and demographic factors. This piece delves into the unique landscape of depression in Israel, a country with an exceptionally diverse population makeup.

The Broad Impacts of Depression

Depression’s reach extends far beyond personal suffering. In the United States, employees with depression lose an average of 5.6 productive hours per week, costing $44 billion* in wages annually – an excess of $31 billion compared to those without depression. Furthermore, depression often accompanies various medical conditions, such as chronic pain, sleep disorders, diabetes, arthritis, stroke, and heart disease. It may also be an initial manifestation of severe disorders like malignancies or thyroid and adrenal issues.

1. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA 2003;289:3135–44.

The Unique Context of Israel

Israel’s population is highly heterogeneous, encompassing a multitude of cultural backgrounds, beliefs, mother tongues, and customs. Such diversity presents a significant challenge in diagnosing and treating depression, particularly amongst the large minority of Arabs and various immigrant groups at a higher risk of depression. Understanding this intricate matrix is vital to providing effective mental health services in Israel.

The Prevalence of Depression in Israel

Depression is the second most common chronic disorder encountered by primary care physicians in Israel, mirroring the prevalence in other Western countries. However, population-specific data is limited. Within the available data, women have been found to express symptoms of depressive episodes more frequently than men (22.0% vs. 13.6%). Moreover, the rate of depression escalates with age, increasing from 11.0% in the youngest group (26-35) to 25.0% in the oldest. Notably, this upward trend is more pronounced for women than for men.2


Gender and Age Disparities in Depression Rates

Depressive symptoms are markedly more prevalent in women than men in Israel, a trend that becomes more pronounced with age. These disparities underscore the need for gender and age-specific mental health strategies. Further research is warranted to discern the underpinning factors of these disparities, which may range from biological differences to societal pressures.

Pre-Covid Depression Statistics

Before the Covid pandemic, the prevalence of current major depressive disorder in Israel ranged from 1.6% to 5.9%. Additionally, the lifetime prevalence of dysthymic disorder, based on patient medical records, was 0.9%. As for minor depression, its current prevalence varied between 1.1% and 5.4%. ref: 3./4./5.

3. Kafman M, Alon N, Hermoni D. Screening for depression in primary care clinics in Israel – how wide is the gap?. Harefuah 2003;142:815–19, 80, 79 (Hebrew)
4. Munitz H, Valevski A, Weizman A, et al. Recognition and treatment of depression in primary care settings in 6 different countries: a retrospective file analysis by WHO. Eur J Psychiatry 2000;14:85–93.
5. Froom J, Aoyama H, Hermoni D, Mino Y, Galambos N. Depressive disorders in three primary care populations: United States, Israel, Japan. Fam Pract 1995;12:274–8 

The Impact of the Covid-19 Pandemic

While specific Israeli data post-pandemic is currently unavailable, global trends suggest that the Covid-19 crisis has likely exacerbated depression rates. The pandemic has brought about numerous stressors, including job loss, illness, and social isolation, known triggers for depression. Consequently, an up-to-date understanding of the current mental health landscape is critical.

Treating Depression: Exploring Ketamine Infusion Therapy

One innovative approach to combating depression has been the introduction of ketamine infusion therapy, a rapid-acting treatment offering hope for those suffering from treatment-resistant depression. In Israel, clinics like Ketamind are pioneering this treatment, providing a unique service in the diverse therapeutic landscape.


Understanding the complex panorama of depression in Israel is integral to delivering effective, culturally sensitive interventions. Despite the challenges posed by Israel’s diversity, it also presents an opportunity to develop a comprehensive and inclusive approach to mental health. Continued research and implementation of novel therapies, like ketamine infusion therapy, will be vital in addressing this pressing issue. As we continue to deepen our understanding, we move closer to a world where everyone receives the care they need regardless of their cultural or demographic background.

Keywords: benefits of ketamine infusion therapy, depression, depression doctor, depression therapy, Ketamind clinic Israel, ketamine infusion therapy, ketamine IV therapy, ketamine therapy, ketamine therapy for depression, ketamine therapy Israel, mental health services in Israel.

Table of Contents